CLINICAL_TRIALS
trial_result
· 2007-11-29
Clinical Trial Update: A Study of ABT-751 in Patients With Renal Cell Cancer [Phase 2]
Summary
A Phase 2 study of ABT-751 in renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Renal Cell Cancer | Phase 2 | Status: COMPLETED